 Thomas Ragole
Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| POEMS Syndrome | 2 | 2021 | 3 | 0.350 |
Why?
| | Ophthalmoplegia | 1 | 2021 | 8 | 0.180 |
Why?
| | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2021 | 5 | 0.180 |
Why?
| | Anemia, Hemolytic, Autoimmune | 1 | 2021 | 15 | 0.180 |
Why?
| | Ataxia | 1 | 2021 | 42 | 0.180 |
Why?
| | Glycogen Storage Disease Type II | 1 | 2020 | 7 | 0.170 |
Why?
| | Enzyme Replacement Therapy | 1 | 2020 | 13 | 0.170 |
Why?
| | alpha-Glucosidases | 1 | 2020 | 12 | 0.170 |
Why?
| | Paraproteinemias | 1 | 2020 | 5 | 0.170 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2020 | 22 | 0.170 |
Why?
| | Amyloid Neuropathies, Familial | 1 | 2020 | 14 | 0.170 |
Why?
| | Amyloidosis | 1 | 2020 | 42 | 0.170 |
Why?
| | Charcot-Marie-Tooth Disease | 1 | 2020 | 21 | 0.170 |
Why?
| | Oligonucleotides | 1 | 2020 | 143 | 0.160 |
Why?
| | Diagnostic Errors | 1 | 2020 | 162 | 0.160 |
Why?
| | Amygdala | 2 | 2011 | 199 | 0.090 |
Why?
| | Septal Nuclei | 1 | 2011 | 20 | 0.090 |
Why?
| | Receptor, Serotonin, 5-HT2C | 1 | 2009 | 15 | 0.080 |
Why?
| | Stress Disorders, Traumatic | 1 | 2009 | 23 | 0.080 |
Why?
| | Cues | 1 | 2011 | 334 | 0.080 |
Why?
| | Cerebral Cortex | 1 | 2011 | 439 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2011 | 1068 | 0.050 |
Why?
| | Anxiety | 1 | 2009 | 972 | 0.050 |
Why?
| | Amyloidogenic Proteins | 1 | 2020 | 16 | 0.040 |
Why?
| | Injections, Spinal | 1 | 2020 | 104 | 0.040 |
Why?
| | Amyloid | 1 | 2020 | 85 | 0.040 |
Why?
| | Social Behavior | 2 | 2011 | 288 | 0.040 |
Why?
| | Genetic Testing | 1 | 2020 | 430 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2020 | 487 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2021 | 1432 | 0.030 |
Why?
| | Middle Aged | 3 | 2021 | 31136 | 0.030 |
Why?
| | Male | 4 | 2021 | 63670 | 0.020 |
Why?
| | Rats | 2 | 2011 | 5483 | 0.020 |
Why?
| | Muscimol | 1 | 2011 | 24 | 0.020 |
Why?
| | Immobility Response, Tonic | 1 | 2011 | 5 | 0.020 |
Why?
| | Microinjections | 1 | 2011 | 86 | 0.020 |
Why?
| | Tetrodotoxin | 1 | 2011 | 39 | 0.020 |
Why?
| | Aged | 2 | 2021 | 22061 | 0.020 |
Why?
| | Humans | 5 | 2021 | 129625 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2011 | 267 | 0.020 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2009 | 9 | 0.020 |
Why?
| | Microdialysis | 1 | 2009 | 51 | 0.020 |
Why?
| | Serotonin Receptor Agonists | 1 | 2009 | 28 | 0.020 |
Why?
| | Serotonin Antagonists | 1 | 2009 | 31 | 0.020 |
Why?
| | Electroshock | 1 | 2009 | 147 | 0.020 |
Why?
| | Neural Pathways | 1 | 2011 | 303 | 0.020 |
Why?
| | Aminopyridines | 1 | 2009 | 98 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 3717 | 0.020 |
Why?
| | Female | 3 | 2021 | 68734 | 0.020 |
Why?
| | Adult | 2 | 2021 | 35599 | 0.020 |
Why?
| | Fear | 1 | 2011 | 354 | 0.020 |
Why?
| | Brain Mapping | 1 | 2011 | 575 | 0.020 |
Why?
| | Serotonin | 1 | 2009 | 318 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 835 | 0.020 |
Why?
| | Indoles | 1 | 2009 | 383 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 1293 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2011 | 2395 | 0.020 |
Why?
| | Young Adult | 1 | 2020 | 12455 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2021 | 14522 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4078 | 0.010 |
Why?
| | Animals | 2 | 2011 | 35391 | 0.010 |
Why?
|
|
Ragole's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|